Diabetes Meds
Davida Kruger discusses SGLT2 medications—a new class of diabetes drugs—and its mechanism of action and the benefits. Interviewed by Mimi Secor, MS, MEd, APRN, BC, FNP, FAANP
December 12, 2013 | Clinician Reviews
Author and Disclosure Information
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
To hear her lecture on “Cost-Effective Diabetes Treatment for the Under-Uninsured,” and earn CE/CME credit, please attend the 2013 MEDS West in Irvine, CA, October 3-5. Click here for complete details.